Veradermics has completed an oversubscribed $150 million Series C financing led by SR One to advance its lead product VDPHL01 through Phase 3 trials for hair regrowth.
PUBLIC · MANEOct 16, 2025
Amount Raised
$150 Million
Round Type
Series C
West HartfordHealthcareHealth Care
Investors
SR One
Description
Veradermics announced the completion of an oversubscribed $150 million Series C financing aimed at supporting the development and NDA submission for VDPHL01, an investigational oral minoxidil treatment. The financing, led by SR One, will help fund ongoing Phase 3 trials. Veradermics has shown promising preliminary Phase 2 data, demonstrating visible hair growth in males. The treatment aims to address the significant need for effective therapies for pattern hair loss.
Who to call at VeraDermics, and when
A new round usually means VeraDermics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day VeraDermics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at VeraDermics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VeraDermics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
VeraDermics
Location
West Hartford, Connecticut, United States
About
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
We are on a mission to make long-ignored dermatology and aesthetics conditions simple, replacing false hope, confusion, and questionable results with solutions that people and providers can trust.
Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in women and men. Pattern hair loss, also known as androgenetic alopecia, is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VeraDermics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
West HartfordHealthcareHealth Care